Syndax Pharmaceuticals Inc (SNDX) stock
SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.45−0.09 (-0.94%)
Close on Nov 13, 2026Market cap $843.86MP/E –Yield –
Syndax Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Syndax Pharmaceuticals's profit margin for the twelve months ending Sep 30, 2026 was -72.3%. For fiscal 2025 it was -165.6%, against -1346.1% the year before. The highest annual figure on record is 17.8% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -165.6% | +1180.5 |
| FY2024 | Dec 31, 2024 | -1346.1% | −1363.9 |
| FY2021 | Dec 31, 2021 | 17.8% | +4840.4 |
| FY2020 | Dec 31, 2020 | -4822.5% | −1127.9 |
| FY2019 | Dec 31, 2019 | -3694.6% | +1180.9 |
| FY2018 | Dec 31, 2018 | -4875.5% | −1991.1 |
| FY2017 | Dec 31, 2017 | -2884.3% | +760.9 |
| FY2016 | Dec 31, 2016 | -3645.2% | +201.5 |
| FY2015 | Dec 31, 2015 | -3846.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -59.3% | +73.0 |
| Q2 FY2026 | Jun 30, 2026 | -67.8% | +121.5 |
| Q1 FY2026 | Mar 31, 2026 | -65.8% | +357.6 |
| Q4 FY2025 | Dec 31, 2025 | -99.0% | +1127.2 |
| Q3 FY2025 | Sep 30, 2025 | -132.4% | +540.6 |
| Q2 FY2025 | Jun 30, 2025 | -189.3% | +1755.4 |
| Q1 FY2025 | Mar 31, 2025 | -423.3% | −499.3 |
| Q4 FY2024 | Dec 31, 2024 | -1226.2% | −1059.4 |
| Q3 FY2024 | Sep 30, 2024 | -673.0% | +5371.8 |
| Q2 FY2024 | Jun 30, 2024 | -1944.7% | +5370.1 |
| Q4 FY2021 | Dec 31, 2021 | 76.0% | +5450.5 |
| Q3 FY2021 | Sep 30, 2021 | -166.8% | +5225.6 |
| Q2 FY2021 | Jun 30, 2021 | -6044.9% | −1543.0 |
| Q1 FY2021 | Mar 31, 2021 | -7314.8% | −3294.7 |
| Q4 FY2020 | Dec 31, 2020 | -5374.5% | −1690.3 |
| Q3 FY2020 | Sep 30, 2020 | -5392.3% | −2007.4 |
| Q2 FY2020 | Jun 30, 2020 | -4501.8% | −566.2 |
| Q1 FY2020 | Mar 31, 2020 | -4020.1% | −246.4 |
| Q4 FY2019 | Dec 31, 2019 | -3684.2% | +1272.9 |
| Q3 FY2019 | Sep 30, 2019 | -3385.0% | +1189.7 |
| Q2 FY2019 | Jun 30, 2019 | -3935.6% | +916.1 |
| Q1 FY2019 | Mar 31, 2019 | -3773.6% | +1344.6 |
| Q4 FY2018 | Dec 31, 2018 | -4957.1% | −3355.8 |
| Q3 FY2018 | Sep 30, 2018 | -4574.7% | +372.2 |
| Q2 FY2018 | Jun 30, 2018 | -4851.7% | −379.9 |
| Q1 FY2018 | Mar 31, 2018 | -5118.2% | −865.4 |
| Q4 FY2017 | Dec 31, 2017 | -1601.3% | +1944.6 |
| Q3 FY2017 | Sep 30, 2017 | -4946.9% | – |
| Q2 FY2017 | Jun 30, 2017 | -4471.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -4252.8% | – |
| Q4 FY2016 | Dec 31, 2016 | -3545.9% | – |
See a number that looks wrong?